Cwm LLC Sells 1,028 Shares of Azenta, Inc. (NASDAQ:AZTA)

Cwm LLC lessened its stake in shares of Azenta, Inc. (NASDAQ:AZTAFree Report) by 53.6% in the 1st quarter, according to its most recent 13F filing with the Securities and Exchange Commission (SEC). The firm owned 889 shares of the company’s stock after selling 1,028 shares during the quarter. Cwm LLC’s holdings in Azenta were worth $31,000 at the end of the most recent reporting period.

Other hedge funds and other institutional investors have also modified their holdings of the company. LPL Financial LLC grew its position in Azenta by 31.4% in the fourth quarter. LPL Financial LLC now owns 50,342 shares of the company’s stock valued at $2,590,000 after acquiring an additional 12,033 shares during the period. Norges Bank acquired a new stake in shares of Azenta in the 4th quarter valued at $25,403,000. Franklin Resources Inc. bought a new stake in shares of Azenta in the 4th quarter worth about $256,000. Headlands Technologies LLC bought a new stake in shares of Azenta in the 4th quarter worth about $40,000. Finally, Landscape Capital Management L.L.C. acquired a new stake in shares of Azenta during the 4th quarter worth about $217,000. Institutional investors own 99.08% of the company’s stock.

Azenta Stock Up 0.2%

Azenta stock opened at $32.41 on Tuesday. The stock has a 50-day simple moving average of $31.03 and a 200 day simple moving average of $34.91. The stock has a market capitalization of $1.48 billion, a price-to-earnings ratio of -23.32 and a beta of 1.59. Azenta, Inc. has a 12-month low of $23.91 and a 12-month high of $60.60.

Azenta (NASDAQ:AZTAGet Free Report) last posted its quarterly earnings data on Wednesday, May 7th. The company reported $0.05 earnings per share for the quarter, missing the consensus estimate of $0.09 by ($0.04). Azenta had a negative net margin of 10.31% and a positive return on equity of 1.30%. During the same quarter last year, the firm posted $0.06 earnings per share. The business’s revenue for the quarter was up 5.1% on a year-over-year basis. As a group, sell-side analysts anticipate that Azenta, Inc. will post 0.53 EPS for the current year.

Wall Street Analysts Forecast Growth

A number of research firms have commented on AZTA. Evercore ISI boosted their price target on shares of Azenta from $29.00 to $35.00 and gave the company an “in-line” rating in a research report on Tuesday, July 8th. Needham & Company LLC cut their target price on shares of Azenta from $59.00 to $40.00 and set a “buy” rating for the company in a research note on Wednesday, May 7th. Finally, Stephens initiated coverage on Azenta in a report on Tuesday, July 22nd. They issued an “equal weight” rating and a $35.00 target price on the stock.

Get Our Latest Stock Report on AZTA

Azenta Company Profile

(Free Report)

Azenta, Inc provides biological and chemical compound sample exploration and management solutions for the life sciences market in North America, Africa, China, the United Kingdom, rest of Europe, the Asia Pacific, and internationally. The company operates in two reportable segments, Life Sciences Products and Life Sciences Services.

Recommended Stories

Want to see what other hedge funds are holding AZTA? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for Azenta, Inc. (NASDAQ:AZTAFree Report).

Institutional Ownership by Quarter for Azenta (NASDAQ:AZTA)

Receive News & Ratings for Azenta Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Azenta and related companies with MarketBeat.com's FREE daily email newsletter.